Monitoring of glycemic balance in diabetics living in Africa: A review of glycated hemoglobin measurement methods;Surveillance de l'équilibre glycémique chez les diabétiques en Afrique: Une revue des dosages d'hémoglobine glyquée

Cahiers Sante

Volumn 12, Issue 3, 2002, Pages 337-341

  Rahlenbeck, Sibylle I ^a,b  

^a District Sanitaire de Byumba   (Rwanda)

^b NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSAMINE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C;

AFRICA; ANALYTIC METHOD; ANALYTICAL EQUIPMENT; CHRONIC DISEASE; CITY; COLUMN CHROMATOGRAPHY; DEVELOPING COUNTRY; DIABETES CONTROL; DIABETES MELLITUS; DIAGNOSTIC VALUE; ETHNIC GROUP; EXPERT SYSTEM; FOLLOW UP; FUTUROLOGY; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE SYSTEM; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; METHODOLOGY; PATIENT MONITORING; PRACTICE GUIDELINE; PREGNANCY COMPLICATION; PREVALENCE; REFERENCE VALUE; REVIEW; SICKLE CELL ANEMIA; THALASSEMIA;

AFRICA; BLOOD GLUCOSE; CHROMATOGRAPHY; COST CONTROL; COSTS AND COST ANALYSIS; DIABETES MELLITUS; ETHNIC GROUPS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOASSAY; MONITORING, PHYSIOLOGIC; PATIENT COMPLIANCE; PUBLIC HEALTH; REFERENCE VALUES;

EID: 18244421844     PISSN: 11575999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. McLarty DG, Politt C, Swai AB. Diabetes in Africa. Diabet Med 1990; 7: 670-84.
2. King H, Rewers M. Diabetes in adults is now a third world problem: The WHO Ad Hoc Diabetes Reporting Group. Bull WHO 1991; 69: 643-8.
3. Gill G, Mbanya JC, Alberti KG. Diabetes in Africa. Cambridge: Biddies Ltd., 1997; 294 p.
4. Sidibe H. Le diabète sucré en Afrique subsaharienne. Cahiers Santé 1998; 8: 342-6.
5. Kalk WJ, Osler CE, Taylor D, Panz VR. Prior long-term glycaemic control and insulin therapy in insulin-dependent diabetic adolescent with microàlbuminuria. Diabet Res Clin Pract 1990; 9: 83-8.
6. Kaimbo DK, Kabongo BK, Missotten L. Complications oculaires chez les diabétiques zaïrois. Bull Soc Beige Ophtalmol 1995; 255: 107-13.
7. Drabo PY, Kabore Y, Lengani A. Complications diabétiques au centre hospitalier de Ouagadougou. Bull Soc Pathol Exot 1996; 89: 191-5.
8. Cisse A, Chevenue D, Chauffert M, Ndinye MR, Wade A, Trivin F. HLA et rétinopathie diabétique chez les Sénégalais. Dakar Med 1998; 43: 29-33.
9. Sobgnwi E, Mbanya JC, Moukouri EN, Ngu KB. Microalbuminuria and retinopathy in a diabetic population in Cameroon. Diabet Res Clin Pract 1999; 44: 191-6.
10. Reiber GE, King H. Guidelines for the Development of National Programs for Diabetes Mellitus. Geneva: World Health Organization, 1991.
11. Leutenegger M. L'hémoglobine glyquée estelle toujours un bon marqueur du contrôle glycémique au long cours chez les patients diabétiques? Diabetes Metab (Paris) 1991; 17: 424-6.
12. Nathan JM, Singer DE, Hurxthal K, Goodson JD. The clinical information value of glycated hemoglobin assay. New Engl J Med 1984; 310: 341-6.
13. Cohen MP, Clements RS. Measuring glycated proteins: Clinical and methodological aspects. Diab Techn Therap 1999; 1: 57-60.
14. 1c: Concentration clinico-biologique pour la standardisation des méthodes de dosage. Diabetes Metab (Paris) 1999; 25: 283-7.
15. Little RR, Wiedmeyer HM, England JD, Naito HK, Goldstein DE. Interlaboratory comparison of glycohaemoglobin results: College of American Pathologists survey data. Clin Chem 1991; 37: 1725-9.
16. 1c) measurements in subjects with haemoglobin variants using the DCA 2000. Ann Clin Biochem 1997; 34: 205-7.
17. Bodor GS, Little RR, Garett N, Brown W, Goldenstein DE, Nahm MH. Standardization of glycohemoglobin determinations in the clinical laboratory. Clin Chem 1992; 38: 2414-8.
18. Mortensen HB, Nielsen L, Soegaard U, Svendsen PA, Nerup J. Comparison of six assays for glycated hemoglobin determination. Scand J Clin Lab Invest 1993; 33: 357-62.
19. 1c measurements by various methods. Clin Chem Lab Med 2000; 38: 321-2.
20. Miedema K. Influence of hemoglobin variants on the determination of glycated hemoglobins. Clin Lab 1993; 39: 1029-32.
21. 1c determination and hemoglobinopathies: Problems and strategies. Ann Biol Clin 2000; 58: 425-9.
22. 1c determination methods in patients with hemoglobinopaghies. Diabetes Care 2000; 23: 339-44.
23. 1c using precalibrated unitized reagent cartridges. Clin Chem 1992; 38: 234-45.
24. 1c. Clin Chem 1993; 39: 663-6.
25. 1c immunoassay method (DCA 2000). Horm Metab Res 1994; 26: 615-6.
26. 1c under field conditions in Tanzania. Diabet Res Clin Pract 1998; 40: 123-8.
27. 1c by an immunoassay method. Diabet Care 1998; 21: 983-6.
28. 1 levels in Nigerian diabetic patients using microcolum affinity chromatography. Afr J Med Sci 1986; 15: 49-53.
29. Turpeinen U, Karjaleinen U, Stenman UH. Three assays for glycohemoglobin compared. Clin Chem 1995; 41: 191-5.
30. Weykamp CW, Penders TJ, Muskiet FA, van der Silk W. Glycohaemoglobin: A comparison of 12 analytical methods applied to lyophilized haemolysates by 101 laboratories in an external quality assurance program. Ann Clin Biochem 1993; 30: 169-74.
31. 1c analyzer. Diabet Med 1993; 10: 976-9.
32. 1c glycated albumin, and fructosamine and analysis of their weight functions against preceeding plasma glucose levels. Diabetes Care 1995; 18: 440-7.
33. 1c) in Africans: Preliminary findings with the microcolumn technique. Trop Geogr Med 1983; 35: 347-51.
34. 1c in evaluation of diabetic control in Kenyan Africans. East Afr Med J 1983; 60: 60-3.
35. Gomo ZA. The determination of glucose and glycosylated haemoglobins in a non-diabetic Zimbabwean African population. Ann Clin Biochem 1985; 22: 362-5.
36. Gebre-Yohannes A, Rahlenbeck SI. Glycaemic control and its determinants in diabetic patients in Ethiopia. Diabet Res Clin Pract 1997; 35: 129-34.
37. Gilbert RE, Tsalamandris C, Bach LA, et al. Long-term control and the rate of progression of early kidney disease. Kidney 1993; 44: 855-9.
38. Klein R, Klein BE, Moss SE, Cruickshanks K. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 1994; 154: 169-78.
39. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998; 352: 837-53.
40. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabets mellitus. New Engl J Med 1993; 329: 977-86.
41. European IDDM policy group. Consensus guidelines for the management of insulindependent (type 1) diabetes. Diabet Med 1993; 10: 990-1005.
42. American Diabetes Association. Implications of the diabetes control and complications trial. Diabet Care 2001; 24: S25-6.
43. Drouin P, Blicke JF, Charbonnel B, et al. Diagnostic et classification du diabète sucré. Les nouveaux critères. Diabetes Metab 1999; 25: 72-83.
44. Alberti KH, Gries FA. Management of noninsulin dependant diabetes mellitus in Europe: A consensus view. Diabet Med 1988; 5: 275-81.
45. Rahlenbeck SI. Monitoring diabetic control in developing countries: A review of glycated haemoglobin and fructosamine assays. Trop Doct 1998; 28: 9-15.
46. 1c values. Ann Intern Med 2000; 18: 676.
47. 1c. Am J Med Qual 2000; 15: 196.